Stephen Joseph Balevic, MD

Assistant Professor of Pediatrics
Assistant Professor of Medicine
Member of the Duke Clinical Research Institute
Email address stephen.balevic@duke.edu

I am an adult and pediatric rheumatologist and care for patients with a wide variety of autoimmune and rheumatic diseases, including: systemic lupus, rheumatoid arthritis, juvenile arthritis, vasculitis, and sarcoidosis, among others.

I am also a clinical researcher focusing on precision medicine, clinical pharmacology, and drug trials.

Education and Training

  • Clinical Pharmacology Fellowship, Duke And Unc School Of Pharmacy, Duke University School of Medicine, 2016 - 2018
  • Clinical Research Fellow, Dcri, Duke University School of Medicine, 2016 - 2018
  • Fellowship Adult and Pediatric, Pediatrics, Duke University School of Medicine, 2014 - 2018
  • Internal Medicine and Pediatric Residency, Medical University of South Carolina School of Medicine, 2010 - 2014
  • M.D., Marshall University, 2010

Publications

Thompson, Elizabeth J., Huali Wu, Anil Maharaj, Andrea N. Edginton, Stephen J. Balevic, Marjan Cobbaert, Anthony P. Cunningham, Christoph P. Hornik, and Michael Cohen-Wolkowiez. “Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children..” Clin Pharmacokinet 58, no. 7 (July 2019): 887–98. https://doi.org/10.1007/s40262-018-00733-1.

PMID
30840200
Full Text

Watt, Kevin M., Christoph P. Hornik, Stephen J. Balevic, Gratias Mundakel, C Michael Cotten, Barrie Harper, Daniel K. Benjamin, et al. “Pharmacokinetics of ticarcillin-clavulanate in premature infants..” Br J Clin Pharmacol 85, no. 5 (May 2019): 1021–27. https://doi.org/10.1111/bcp.13882.

PMID
30710387
Full Text

Balevic, Stephen J., P Brian Smith, Daniela Testoni, Huali Wu, Kim L. R. Brouwer, Kanecia O. Zimmerman, Nazario D. Rivera-Chaparro, Daniel K. Benjamin, and Michael Cohen-Wolkowiez. “Cefazolin pharmacokinetics in premature infants..” J Perinatol, April 3, 2019. https://doi.org/10.1038/s41372-019-0368-z.

PMID
30944398
Full Text

Balevic, Stephen J., Thomas P. Green, Megan E. B. Clowse, Amanda M. Eudy, Laura E. Schanberg, and Michael Cohen-Wolkowiez. “Pharmacokinetics of Hydroxychloroquine in Pregnancies with Rheumatic Diseases..” Clin Pharmacokinet 58, no. 4 (April 2019): 525–33. https://doi.org/10.1007/s40262-018-0712-z.

PMID
30255310
Full Text

Balevic, Stephen J., Michael Cohen-Wolkowiez, Amanda M. Eudy, Thomas P. Green, Laura E. Schanberg, and Megan E. B. Clowse. “Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes..” J Rheumatol 46, no. 1 (January 2019): 57–63. https://doi.org/10.3899/jrheum.180158.

PMID
30275257
Full Text

Wang, Laura A., P Brian Smith, Matthew Laughon, Ronald N. Goldberg, Lawrence C. Ku, Kanecia O. Zimmerman, Stephen Balevic, et al. “Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants..” Early Hum Dev 125 (October 2018): 26–30. https://doi.org/10.1016/j.earlhumdev.2018.08.009.

PMID
30193125
Full Text

Balevic, Stephen J., and Michael Cohen-Wolkowiez. “Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children..” Journal of Clinical Pharmacology 58 Suppl 10 (October 2018): S58–72. https://doi.org/10.1002/jcph.1053.

PMID
30248192
Full Text

Mater, Heather van, Stephen J. Balevic, Gary L. Freed, and Sarah J. Clark. “Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists..” Arthritis Care Res (Hoboken) 70, no. 2 (February 2018): 268–74. https://doi.org/10.1002/acr.23273.

PMID
28464558
Full Text

Balevic, Stephen J., Mara L. Becker, Michael Cohen-Wolkowiez, and Laura E. Schanberg. “Clinical Trial Design in Juvenile Idiopathic Arthritis..” Paediatr Drugs 19, no. 5 (October 2017): 379–89. https://doi.org/10.1007/s40272-017-0244-2.

PMID
28612093
Full Text

Pages